1/n Our first #CurePF paper for 2023 is OUT! A novel role in Pulmonary Fibrosis for miR-33, a key regulator of macrophage immuno-metabolic response & mitochondrial function, providing evidence that inhibition may be antifibrotic
#miR33PFPaper
https://doi.org/10.1172/jci.insight.158100
JCI Insight - microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis

So it starts! Dr. Erica Herzog is giving the 9th Annual Jack A. Elias Advances in Biomedical Sciences Lecture in @[email protected]
Medical Grand Rounds: "Nerve-Lung Interactions in Pulmonary Fibrosis"
#CurePF
#GreatYaleTalks
#ThisIsYalePCCSM
From #BestFellows to #BestFaculty

Rheum ILD community seeing a paper showing data on 3 RA-ILD lungs, bleo: WOW, that’s cool, LET’s try it.

IPF community seeing a paper with lots of human tissues, multiple mice models, PCLS, safety data: Can you do ferrets?

I think rheum will
#CurePF 😍

Is Vista (PD-1H) the most important #Checkpoint immune regulator you never heard of? Fascinating implications for the role of innate immunity in #PulmonaryFibrosis. Kudos Drs Kim, Kang & team of collaborators #CurePF #ImmuneSystem
https://www.atsjournals.org/doi/10.1165/rcmb.2022-0219OC
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis

@Roberttighe hashtags more important on this clanky echo chamber than on #MedTwitter , make sure to follow #CurePF or #CureIPF #PCCMEats #CleanAir maybe introduce others
And so it starts! The first ever Pulmonary Fibrosis Stakeholder Summit! Sponsored by NIH-NHLBI, TLF, PFF, DOD, others! Really exciting and an important step on the road to #CurePF